- Home
- ACIU vs LCNB Comparison
ACIU vs LCNB Comparison
Compare ACIU & LCNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ACIU | LCNB |
|---|---|---|
| Founded | 2003 | 1877 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 213.3M | 238.1M |
| IPO Year | 2015 | 1999 |
Fundamental Metrics
Financial Performance| Metric | ACIU | LCNB |
|---|---|---|
| Price | $3.01 | $17.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 321.4K | 19.7K |
| Earning Date | 01-01-0001 | 04-30-2026 |
| Dividend Yield | N/A | ★ 5.23% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.23 |
| Revenue | N/A | ★ $6,445,000.00 |
| Revenue This Year | N/A | $8.50 |
| Revenue Next Year | $495.67 | $3.66 |
| P/E Ratio | ★ N/A | $13.59 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.43 | $13.34 |
| 52 Week High | $4.00 | $17.89 |
Technical Indicators
Market Signals| Indicator | ACIU | LCNB |
|---|---|---|
| Relative Strength Index (RSI) | 53.73 | 46.57 |
| Support Level | $2.54 | $15.24 |
| Resistance Level | $3.92 | $17.00 |
| Average True Range (ATR) | 0.18 | 0.41 |
| MACD | 0.04 | -0.09 |
| Stochastic Oscillator | 89.39 | 43.70 |
Price Performance
Historical ComparisonAbout ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About LCNB LCNB Corporation
LCNB Corp operates within the financial sector in the United States. As the holding company of the National Bank, it conducts the business of providing commercial and personal banking services. Its suite of banking products includes commercial and industrial loans, consumer loans, safe deposit boxes, night depositories, cashier's checks, utility bill collections and notary public service. Besides, it provides the avenue of United States Treasury notes, the United States agency notes, certificates of deposit, and equity securities.